sb 216763 has been researched along with Brain Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, WJ; Hou, K; Hu, WY; Hu, YX; Jiao, Y; Kang, Q; Liu, SY; Liu, ZY; Lv, KY; Ma, N; Qiu, CW; Xiao, ZC; Zhang, FL; Zhang, L | 1 |
| D'Angelo, B; Ek, CJ; Mallard, C; Sandberg, M; Sun, Y; Zhu, C | 1 |
2 other study(ies) available for sb 216763 and Brain Infarction
| Article | Year |
|---|---|
Wip1 knockout inhibits neurogenesis by affecting the Wnt/β-catenin signaling pathway in focal cerebral ischemia in mice.
Topics: Animals; beta Catenin; Brain Infarction; Bromodeoxyuridine; Disease Models, Animal; Doublecortin Domain Proteins; Enzyme Inhibitors; Gene Expression Regulation; In Situ Nick-End Labeling; Indoles; Infarction, Middle Cerebral Artery; Male; Maleimides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Protein Phosphatase 2C; Severity of Illness Index; Statistics, Nonparametric; Wnt Signaling Pathway | 2018 |
GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.
Topics: Animals; Animals, Newborn; Brain; Brain Infarction; Caspase 3; Cerebrovascular Circulation; Disease Models, Animal; Doublecortin Domain Proteins; Drug Administration Schedule; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Hypoxia-Ischemia, Brain; Indoles; Maleimides; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neuropeptides; STAT3 Transcription Factor; Stem Cells; Subcellular Fractions | 2016 |